Duke Selects Logos Electronic Data Capture Software
Posted on: Friday, 27 June 2008, 09:03 CDT
Duke University Medical Center has licensed Logos Technologies's Alphadas, an electronic data capture software to accelerate and streamline its early-phase clinical trials and to enable physicians to follow patients more closely.
Duke, which will become the first academic medical center in the country to use the Alphadas system, believe the technology has the potential to be a more accurate, real-time system that may improve the safety of clinical trial participants and contribute to more timely development of new drugs.
Duke will pay for the project through support from the clinical and translational science award, a five-year, $53 million grant from the National Institutes of Health awarded to Duke in 2006.
Giles Wilson, co-founder of Logos, said: "We look forward to this opportunity to work with Duke, a leading and world class academic medical center. The partnership will help us achieve our mission to reduce the development time of life-saving and life-enhancing drugs."
Source: Datamonitor
Related Articles
- Omeros and The Parkinson's Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
- CIGNA and Dartmouth-Hitchcock Launch ''Patient-Centered Medical Home'' Program to Provide Better Care Coordination
- American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards
- The National Institutes of Health Clinical Center Licenses TheraDoc(R)
- NCQA Program to Evaluate Patient-Centered Medical Homes
- LSU Health Sciences Center Medical Informatics and Telemedicine Program Selects Eceptionist Solution
- Kemeta and Obesity Treatment Center Medical Group of Sacramento to Collaborate in Unique Weight Loss Study
- BioServe Selected By Specialized Clinical Center of Research for Study on Thoracic Aortic Disease
- Scios Selects Duke Clinical Research Institute (DCRI) to Lead Landmark International Outcomes Trial of NATRECOR(R) (Nesiritide)
- Food and Drug Administration and Duke Clinical Research Institute to Host a Cardiac Safety Think Tank
 |
 |
User Comments (0)
RSS Feeds